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Abstract
Purpose Graves’ orbitopathy (GO) is an extraocular eye dis-
ease with symptoms ranging from minor discomfort from dry
eyes to strabismus and visual loss. One of the hallmarks of
active GO is visible hyperemia at the insertion of the
extraocular muscles. The aim of the present study was to eval-
uate the use of enhanced-depth imaging spectral domain
anterior segment optical coherence tomography (EDI SD
AS-OCT) for detecting pathological changes in horizontal
recti muscles of patients with GO.
Methods Prospective cross sectional study of 27 eyes. Only
women were included. EDI AS-OCTwas used to measure the
thickness of the tendons of the horizontal recti muscles in a
predefined area in patients with GO and healthy controls.
Results EDI AS-OCT was able to image the tendons of the
horizontal recti muscles in both healthy controls and
patients suffering from GO. The mean thickness of the
medial rectus muscle (MR) tendon was 256.4 μm
[±17.13 μm standard deviation (SD)] in the GO group
and, therefore, significantly thicker (p=0.046) than in the
healthy group which had a mean thickness of 214.7 μm
(±5.516 μm SD). There was no significant difference in the
mean thickness of the tendon of the lateral recti muscles (LRs)
between these groups.
Conclusion This is the first report showing that EDI AS-OCT
is suitable to detect swelling at the insertion site of the MR
muscle in GO. MR tendon thickness may be a useful param-
eter to monitor activity in these patients.
Keywords Extraocular eye muscles .Myopathy . Anterior
segment OCT . Graves’ orbitopathy
Introduction
Graves’ disease represents the most common cause of hyper-
thyroidism in adults [1]. In addition to the thyroid, the skin and
the eyes may be involved as well [1]. Orbital involvement is
known as Graves’ orbitopathy or ophthalmopathy (GO) or as
thyroid eye disease (TED) [2]. Rarely, GO is associated with
Hashimoto thyroiditis, euthyroid or hypothyroid patients[1].
The pathogenetic mechanisms of GO have not yet been
fully resolved. It is known that antibodies against the thyroid
stimulating hormone (TSH) receptors play an important
role. TSH receptors can not only be found in the thyroid, but
also in the extraocular eye muscles and retrobulbar fat tissue.
It is thought that circulating TSH-receptor autoantibodies
(TRAbs) trigger inflammation and activation of orbital fibro-
blasts leading to intraorbital swelling and, subsequently, to
fibrosis at a later stage. Accordingly, circulating TRAbs can
be detected in the blood and are detected in most GO patients
[3].
Active GO is characterized by an inflammatory response
which may involve the ocular surface, extraocular muscles
and other orbital tissue. Depending on the site of inflamma-
tion, the disease may cause dry eye symptoms or conjunctival
chemosis, while the increased orbital volumemay cause prop-
tosis and eye movement disorders. The inferior rectus muscle
and the MRmuscle are primarily affected [4]. Due to potential
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severe GO morbitity, patients with a moderate-to-severe de-
gree require treatment ranging from nonsteroidal anti-inflam-
matory drugs (NSAIDs) to orbital irradiation and surgical de-
compression [5]. However, the mainstay treatment is steroids,
which may cause significant side effects. For efficient treat-
ment, an effective treatment monitoring is important.
Clinical assessment is the foundation for the diagnosis of
GO and the clinical activity score (CAS) has emerged as a
useful tool for assessing GO activity [6, 7].
In order to quantify disease activity, several imaging mo-
dalities have been described in the literature; sonography of
the orbita is a fast and a non-invasive imaging method to
determine the stage of GO on the basis of muscle thickness
and reflectivity. However, sonography of the extraocular mus-
cles has a long learning curve and the quality of this method is
strongly dependent on the examiner’s experience [4].
Magnetic resonance imaging (MRI) [8, 9] and computed
tomography (CT) have been used to determine the degree of
proptosis, mainly for surgical planning of elective orbital de-
compression. However, they are not useful for repetitive mon-
itoring of disease activity [10].
In this study, we assess the usefulness of optical coherence
tomography (OCT) to image the extraocular muscles in GO
and whether it may serve as a tool to detect active GO.
Materials and methods
This study was approved by the local ethics commission (KEK
178/12) and conformed to the provisions of the Declaration of
Helsinki. Informed consent was obtained in written form from
each individual. The patients and subjects were recruited from
the outpatient clinic of the Department of Ophthalmology at the
University Hospital Bern, Switzerland. For each patient with
GO, a questionnaire according to the guidelines of EUGOGO
(European Group of Graves’ Orbitopathy) was completed and
the CAS was calculated by screening the patient for the follow-
ing seven signs of activity: 1. moderate to severe active lid
swelling, 2. eyelid erythema, 3. definite conjunctival redness,
4. chemosis, 5. caruncle or plical inflammation, 6. spontaneous
orbital pain, 7. gaze-evoked orbital pain [6, 7].
To image the anterior segment of the eye, the ‘anterior
segment module’ of a spectral domain OCT (SD OCT;
Heidelberg Engineering GmbH, Heidelberg, Germany) was
used. The zoom was set to zero and the program was changed
to ‘sclera mode’ with enhanced depth imaging (EDI).
Ambient light was reduced to nearly zero lux for noise reduc-
tion. The patient was asked to focus his eyes on the external
fixation light which was mounted at an angle of 45° to the left
and to the right, consecutively (see Fig. 1). The images were
taken in ‘grid mode’ at high resolution. The grid was 30° wide
and 5° high, resulting in 11 sections (278 μm between the
sections; see Fig. 2a). Depending on the compliance of the
patient, 9 or 16 frames were chosen. For the lateral rectus
muscle, the grid was rotated by +5.5°, for the medial rectus
(MR) muscle by -5.5°. These settings delivered high resolu-
tion images (1536 x 496 pixels) with a wide viewing angle
and sections running parallel to the tendon. Infrared (IR) im-
ages were obtained at a resolution of 1536 x 1536 pixels.
Measurement sites were chosen at 8.7 mm from the limbus
for the MRmuscles and at 9.8 mm from the limbus for the LR
muscles , according to the insertion site of the horizontal mus-
cles. At these predefined sites, the thickness of three OCT
scans were averaged. Care was given to not include the
episclera and the conjunctiva in the muscle thickness measure-
ments (Fig. 2a).
Statistically significant differences were determined using
an unpaired two-tailed Student’s test, and linear regression
analysis was performed to correlate CAS with muscle thick-
ness measurements. P values less than 0.05 were defined as
statistically significant. GraphPad Prism version 5 for
Windows (GraphPad Software Inc. La Jolla, California,
U.S.A) was used to perform statistical data analysis.
Results
All study participants were female. The patient group
included 15 women with a mean age of 48 years (±15 years
standard deviation [SD]), a mean weight of 69 kg (±13.56 kg
SD) and a mean height of 164 cm (±7.6 cm SD). Of these
15 patients, 10 smoked or had stopped smoking recently.
Fig. 1 Representative patient with graves orbitopathy. Both horizontal extraocular eyemuscle insertions (LR=lateral rectus, MR=medial rectus) of both
eyes (RE=right eye, LE=left eye) were imaged. OCT of LR (top) and MR (bottom)
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The control group of healthy volunteers included 12 wom-
en with a mean age of 56 years (±16.0 years SD), a mean
weight of 71 kg (±17.4 kg SD) and a mean height of 166 cm
(±6.7 cm SD). Seven women smoked.
The CAS of all controls was 0 with no history of thyroid
disease. In the patient group, three patients had a CAS of zero,
four patients had a CAS of 1, three patients had a CAS of 2,
one patient each had a CAS of 3 and 4, and three patients had a
CAS of 6.
The mean thickness of the tendon of the MR muscle in the
GO group was 256.4 μm (±17.13 μm SD), significantly
thicker than the same region of the MR in the healthy group
with a mean value of 214.7 μm (±5.52 μm SD) (p=0.0;
Fig. 3). Correlation of the CAS with the thickness of the MR
at the area of insertion was significant (see Fig. 4, R2=0.5, p=
0.0027). The thickness at the insertion site of the LR (mean of
LR OD and LR OS) on the other hand was not significantly
different between the GO group (263.8 μm±57.69 μm SD)
and the healthy group (254.9 μm±8.59 μm SD; p=0.6).
Discussion
In this study, we found that the tendons of the horizontal recti
muscles can be readily imaged with AS-OCT. We show that
the MR muscle insertion area shows significant thickening in
patients with GO. To the best of our knowledge, this is the first
paper to provide evidence about the use of AS-OCT in GO.
Amyriad of clinical signs have been described to assess the
activity of GO in patients. Vascular injection around the inser-
tion sites of the extraocular muscles has been described as the
Topolanski’s sign. Swelling of the extraocular muscles has
proven as a valuable tool to distinguish an acute inflammatory
active disease from an inactive disease by demonstrating in-
terstitial oedema within the extraocular muscles. Several im-
agingmodalities have been proposed tomonitor muscle swell-
ing, including ultrasonography.
Ultrasound uses high frequencies of up to 8 MHz and,
therefore, offers excellent penetration into the orbit.
However, orbital ultrasound is not widely available and has
Fig. 2 EDI anterior segment imaging of the LR muscle. a) IR image of
the LR eye muscle insertion of a healthy RE. Green lines correspond to
the 11 OCT scans. The yellow dashed line marks the locations where
tendon thickness was measured on the OCT scans, 9.8 mm (yellow
solid line) from the limbus (black dashed line). b) AS-OCT scan
correlating to the bright green line on the IR image. Black dashed line
marks the scleral spure. The reddish area highlights the muscle insertion
while the orange area corresponds to the episclera on it. c) Enlarged
illustration of the area 9.8 mm from the scleral spur. d) Enlarged area of
the scleral spur
Fig. 3 Thickness of the horizontal muscle at the insertion site measured
by EDI AS-OCT. a) Measurement of MR of the RE of a GO patient. b)
Measurement of MR of the RE of a healthy subject (NO). The graph
shows the mean tendon thickness measured in the patient group (GO,
n=15) and subject group (NO, n=12). *p<0.05
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a high intra- and interobserver variability in the measurements
of muscle thickness [4]. With the increasing popularity of
OCT for retinal diseases, OCT has become a widely available
tool for ophthalmologist. The noninvasive, noncontact imag-
ing modality of OCT can acquire cross-sectional scans of the
anterior segment and has been used to image the anterior
chamber angle as an adjunct diagnostic tool for glaucoma
specialists [11, 12] and has become an increasingly popular
tool for imaging the cornea [13, 14]. EDI OCT uses the same
wavelength of light as conventional retinal OCT, namely
830 nm, and, therefore, only offers limited penetration of the
sclera. Using EDI, the OCT probe is placed closer to the eye
than normal, resulting in an inverted image with the most
tightly focused illumination at the level of the sclera, allowing
for better penetration of the scleral tissue. Using EDI OCTwe
were able to identify the lower end of the horizontal recti
muscle tendon as a sharply defined border to the sclera.
However the border between the tendon and episclera was
sometimes difficult to determine, especially at the muscle in-
sertion into the sclera. A recent report [15] using AS-OCT,
showed the mean limbus-insertion distance to be about
5.7 mm for the MR muscles and 6.8 mm for the LR muscles.
Adding 3 mm to these distances provided us with a clearly
defined measuring point in the muscle insertion area.
Consequently, we determined the thickness of the horizontal
eye muscle insertions. In order to perform reliable thickness
measurements, we measured the muscle 3 mm posterior to the
insertion site.
Our study has several limitations, including the small num-
ber of and the low clinical activity score in our patients.
Nevertheless, even with this small study group, we could find
significant differences in thickness of the distal end of the MR
muscle between the GO group and the healthy controls. The
preponderance for the involvement of theMRmuscle in GO is
in keeping with previously published data [4]. However, we
are not aware of any previous report using OCT showing that
the tendinous area of the insertion site is affected in GO. In
fact, radiological studies based on CT found that swelling of
the extraocular muscles generally occurs within their bellies
with sparing of the tendons [16]. This is not contradictory to
our findings, as our finding of a greater thickness of about 60
microns is far beyond the detection level of conventional
Fig. 4 Correlation between the CAS and thickness of horizontal muscle at the insertion site in GOpatients measuredwith EDI AS-OCT. A)OCTscan of
a GO patient with CAS 1. B) OCT scan of a GO patient with CAS 6 (n=15, p=0.0027)
Fig. 5 Response to treatment in a patient with active GO using EDI AS-
OCT. A) OCT scan before therapy start. Mean tendon thickness of both
MR muscles was 336 μm. B) OCT scan two months after therapy start.
Mean tendon thickness of bothMRmuscles was 182μm. The red asterisk
in A marks chemosis which showed resolution after therapy
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MRI. In one patient, we were able to obtain longitudinal EDI
OCT before and after therapy with corticosteroids. Here, the
OCT images showed a dramatic reduction of thickness of the
MR muscle over the course of two months (see Fig. 5).
This suggests that AS-OCT may not only be used for diag-
nosis of GO but can be used to monitor the therapeutic re-
sponse as well.
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